Efficacy of Transversalis Fascia Plane Block Versus Wound Infiltration in Varicoselectomy Surgery

November 8, 2022 updated by: Erkan Cem ÇELİK, Ataturk University

Comparison of the Efficacy of Transversalis Fascia Plane Block and Wound Infiltration in Varicoselectomy Surgery; Randomised, Controlled Study.

Before surgery, patients will be divided into 2 groups as transversalis fascia plane block will be applied and skin infiltration will be applied. Post-operative analgesic procedures will be applied to patients receiving general anesthesia. Postoperative analgesic consumption and pain scores of the patients will be evaluated.

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Erzurum, Turkey, 25080
        • Erkan Cem ÇELİK

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Patients over the age of 18 who will undergo Varicocele operation
  • ASA I-II

Exclusion Criteria:

  • Patients with allergic reaction to anesthesia and analgesia drugs to be used
  • Patients who did not want to voluntarily participate in the study
  • Severe systemic disease (kidney, liver, pulmonary, endocrine)
  • Substance abuse history
  • Chronic pain history
  • Psychiatric problems and communication difficulties
  • History of hematological problem
  • Patients with severe hemodynamic instability due to infection, heavy bleeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Wound Infiltration
Wound infiltration will be applied to the surgical incision site for patients in this group. Infiltration fluid will contain 20 ml 0.25% bupivakain.
Block fluids that were prepared as 20 ml 0.25% bupivacaine before the intervention, will be applied through the upper and lower incision lips on the suprainguinal surgical site.
Experimental: Transversalis Fascia Plane Block
Transversalis fascia plane block will be performed on only one periinguinal side for patients in this group. Block fluid will contain 20 ml 0.25% bupivakain.
External, internal oblique, and transversus abdominis muscles will be visualized by the ultrasound device. After transversalis fascia will be seen, transversalis fascia plane block will be performed. As a block fluid 20 ml 0.25% bupivacaine will be applied.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Scores (0 (low)-10 (high))
Time Frame: 1st hour
Pain will be assessed by visual analog scale scores
1st hour
Pain Scores (0 (low)-10 (high))
Time Frame: 2nd hour
Pain will be assessed by visual analog scale scores
2nd hour
Pain Scores (0 (low)-10 (high))
Time Frame: 4th hour
Pain will be assessed by visual analog scale scores
4th hour
Pain Scores (0 (low)-10 (high))
Time Frame: 8th hour
Pain will be assessed by visual analog scale scores
8th hour
Pain Scores (0 (low)-10 (high))
Time Frame: 12th hour
Pain will be assessed by visual analog scale scores
12th hour
Pain Scores (0 (low)-10 (high))
Time Frame: 24th hour
Pain will be assessed by visual analog scale scores
24th hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rescue analgesic consumption
Time Frame: Any time on postsurgical first 24 hour.
Analgesic drug consumption will be assessed
Any time on postsurgical first 24 hour.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 15, 2021

Primary Completion (Actual)

March 15, 2022

Study Completion (Actual)

April 15, 2022

Study Registration Dates

First Submitted

November 23, 2021

First Submitted That Met QC Criteria

December 10, 2021

First Posted (Actual)

December 29, 2021

Study Record Updates

Last Update Posted (Actual)

November 9, 2022

Last Update Submitted That Met QC Criteria

November 8, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ATATÜRK ÜNİVERSİTESİ

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Analgesia

Clinical Trials on Wound site infiltration

3
Subscribe